Skip to main content
VCbacked
Log inGet Started

Mercy BioAnalytics

Natick, United States

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

$59.0M raised
Sep 2025
Series B
BiotechnologyHealth CareLife ScienceTherapeutics

Top Investors

PortfoliaHologicHatteras Venture PartnersSozo VenturesLabCorp

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mercy BioAnalytics

How much funding has Mercy BioAnalytics raised?
Mercy BioAnalytics has raised $59.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.
Who are Mercy BioAnalytics's investors?
Mercy BioAnalytics's investors include Portfolia, Hologic, Hatteras Venture Partners, Sozo Ventures, LabCorp.
Where is Mercy BioAnalytics headquartered?
Mercy BioAnalytics is headquartered in Natick, United States.
What does Mercy BioAnalytics do?
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.
What stage is Mercy BioAnalytics at?
Mercy BioAnalytics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Mercy BioAnalytics — Funding & Investors." VCBacked, September 3, 2025, https://www.vcbacked.co/company/mercy-bioanalytics. Accessed June 17, 2026.
APA
VCBacked. (2025). Mercy BioAnalytics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/mercy-bioanalytics
Wikipedia (cite web)
{{cite web |title=Mercy BioAnalytics — Funding & Investors |url=https://www.vcbacked.co/company/mercy-bioanalytics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong